Global Expansion Strategy for Niche CROs
A US-based niche CRO focused on rare cancer trials partnered with local entities in India and Korea. The global expansion involved:
Click to read the full article.
Contract Research Organizations (CROs)
How Specialty CROs Offer Agile Trial Execution
Agility in clinical trials refers to the ability to rapidly adapt to protocol changes, enroll patients quickly, activate sites efficiently, and manage evolving study needs without compromising compliance or quality. Key indicators of an agile CRO include:
Click to read the full article.
Therapeutic Expertise of Boutique CROs
Boutique CROs are typically smaller, independent organizations that focus on specific therapeutic areas or study phases. Key features include:
Click to read the full article.
Niche CRO Success Stories in Oncology and Orphan Drug Trials
Clinical trials in oncology and orphan diseases face hurdles such as:
Click to read the full article.
Identifying Quality Metrics for Niche CROs
Unlike large CROs with standardized global infrastructures, niche CROs may use tailored SOPs, subcontract partners, and agile workflows. This creates both opportunities and risks:
Click to read the full article.
Key Questions to Ask During CRO Evaluation
CRO selection is not just a procurement exercise—it’s a risk mitigation strategy. Asking the right questions ensures:
Click to read the full article.
Creating a CRO Vendor Selection Matrix
A CRO vendor selection matrix is a decision-support tool used to compare CROs across multiple attributes. It helps sponsors:
Click to read the full article.
Therapeutic Experience vs Operational Capability in CRO Selection
Projects that benefit most from deep therapeutic expertise include:
Click to read the full article.
How to Conduct a CRO Qualification Visit
Qualification visits help sponsors:
Click to read the full article.
Balancing Cost, Quality, and Timelines in CRO Selection
Much like the project management triangle, CRO selection is often a trade-off between:
Click to read the full article.